Application 205367
- Type
- ANDA
- Sponsor
- MYLAN PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MILNACIPRAN HYDROCHLORIDE | MILNACIPRAN HYDROCHLORIDE | TABLET;ORAL | 12.5MG | No | No |
| 002 | MILNACIPRAN HYDROCHLORIDE | MILNACIPRAN HYDROCHLORIDE | TABLET;ORAL | 25MG | No | No |
| 003 | MILNACIPRAN HYDROCHLORIDE | MILNACIPRAN HYDROCHLORIDE | TABLET;ORAL | 50MG | No | No |
| 004 | MILNACIPRAN HYDROCHLORIDE | MILNACIPRAN HYDROCHLORIDE | TABLET;ORAL | 100MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Milnacipran Hydrochloride | MILNACIPRAN HYDROCHLORIDE | Breckenridge Pharmaceutical, Inc. | e39b4890-99e4-4e48-9f45-978d5ac9f402 | 2026-07-24 | Boxed warning, Warnings, Adverse reactions | Milnacipran Hydrochloride MILNACIPRAN HYDROCHLORIDE |
| Milnacipran Hydrochloride | MILNACIPRAN HYDROCHLORIDE | Glenmark Pharmaceuticals Inc., USA | b66b1850-0d2a-41d6-b0ad-c676166394c7 | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | Milnacipran Hydrochloride MILNACIPRAN HYDROCHLORIDE |
| MILNACIPRAN HYDROCHLORIDE | MILNACIPRAN HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | 99efa59a-8458-4e04-8cb1-20abfc179228 | 2026-03-11 | Boxed warning, Warnings, Adverse reactions | MILNACIPRAN HYDROCHLORIDE MILNACIPRAN HYDROCHLORIDE |
| Savella | MILNACIPRAN HYDROCHLORIDE | Cardinal Health 107, LLC | 8b720a1e-034b-4583-b80d-105a794cce74 | 2026-01-26 | Boxed warning, Warnings, Adverse reactions | MILNACIPRAN HYDROCHLORIDE |
| Savella | MILNACIPRAN HYDROCHLORIDE | Allergan, Inc. | 16a4a314-f97e-4e91-95e9-576a3773d284 | 2025-09-10 | Boxed warning, Warnings, Adverse reactions | MILNACIPRAN HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.